A multilayered research framework 1 for humanities and epidemiology of medicinal product risk communication
Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research, Page: 1-84
2020
- 4Citations
- 35Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Modern medicines are among the most successful health interventions, and as such are part of our daily lives and conversations. However, they do not come without risks, and safe use advice from healthcare professionals, conversations between friends and debates in the media are some of the many forms communication about risks with medicines can take. With a view to improving communication for the benefit of patients and society as a whole, this chapter discusses how to approach communication about medicine risks with curiosity and compassion for communication as a vital human behaviour and with consideration for the social spheres where such communication actually happens. Reflecting on past and current safety challenges with medicines, the chapter proposes a multilayered research framework that combines different data types and methods from various scientific disciplines to gain a wider and deeper understanding of the complexity of communication as well as the causal relationships, risk and success factors and pathways towards outcomes. This research approach advocates for the active participation of patients, healthcare professionals and journalists in research and mutual learning. It should generate evidence relevant for communicators in high- and low-income countries alike and prepare the ground for establishing a self-standing inclusive discipline of humanities and epidemiology of medicinal product risk communication.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85089637192&origin=inward; http://dx.doi.org/10.1007/978-981-15-3013-5_1; http://link.springer.com/10.1007/978-981-15-3013-5_1; http://link.springer.com/content/pdf/10.1007/978-981-15-3013-5_1; https://dx.doi.org/10.1007/978-981-15-3013-5_1; https://link.springer.com/chapter/10.1007/978-981-15-3013-5_1
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know